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Abstract
PU.1 is a hematopoietic transcription factor that is required for the development of myeloid and B cells. PU.1 is also
expressed in erythroid progenitors, where it blocks erythroid differentiation by binding to and inhibiting the main erythroid
promoting factor, GATA-1. However, other mechanisms by which PU.1 affects the fate of erythroid progenitors have not
been thoroughly explored. Here, we used ChIP-Seq analysis for PU.1 and gene expression profiling in erythroid cells to show
that PU.1 regulates an extensive network of genes that constitute major pathways for controlling growth and survival of
immature erythroid cells. By analyzing fetal liver erythroid progenitors from mice with low PU.1 expression, we also show
that the earliest erythroid committed cells are dramatically reduced in vivo. Furthermore, we find that PU.1 also regulates
many of the same genes and pathways in other blood cells, leading us to propose that PU.1 is a multifaceted factor with
overlapping, as well as distinct, functions in several hematopoietic lineages.
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Introduction
Cellular identities are established through the actions of master
regulatory transcription factors. In addition to promoting their
lineage-specific gene expression programs, these factors may also
inhibit the transcriptional programs of alternative cell lineages [1].
These inhibitory functions may serve to ensure that genes of
closely related lineages are not mis-expressed [2,3]. The mecha-
nisms used by such transcription factors to inhibit alternative
lineage-specific gene expression are not well understood. The
mutual antagonism between hematopoietic master regulators
PU.1 and GATA-1 has served as an important paradigm, both
for understanding lineage specification as well as these types of
inhibitory interactions.
PU.1 is an Ets family transcription factor that is required for the
development of myeloid and B-cells [4,5]. GATA-1 is a Zn-finger
DNA binding protein that is required for the development of
erythrocytes and megakaryocytes [6]. These two factors have a
particularly close developmental relationship because they direct
lineage commitment from common multipotential progenitors.
Indeed, PU.1 and GATA-1 physically interact and repress each
other’s transcriptional activation and lineage specification func-
tions [7–9].
Although PU.1 is highly expressed in myeloid and B-cells, it is
also normally present in immature erythroid cells [10–12]. Down
regulation of PU.1 is required for erythroid terminal differentia-
tion [11–13]. This property has been conserved throughout
vertebrate evolution [7,14,15]. The Sfpi1 locus encoding PU.1 is
also a frequent target for integration by the spleen-focus-forming
virus during Friend leukemia virus-induced murine erythroleuke-
mia (MEL) [16]. The ability of PU.1 to bind to and repress
GATA-1 transcriptional activity accounts for some of its functions
in erythroid progenitors. However, PU.1 is also a DNA binding
protein, with a number of well-established gene targets that it
regulates in myeloid cells and B-cells [17–20]. Therefore, PU.1
might also regulate important genes in erythroid progenitors.
Several examples of PU.1 gene targets with effects on erythroid
cells have been described recently [11,21,22]. However, it is not
known how many genes PU.1 controls in erythroid cells. Here we
report that PU.1 does indeed direct an extensive transcriptional
network in immature erythroid cells, a network consisting of
pathways that are important for the growth and survival of
PLoS Genetics | www.plosgenetics.org 1 June 2011 | Volume 7 | Issue 6 | e1001392erythroid progenitors. Moreover, we find that several of these
pathways are also regulated by PU.1 in other hematopoietic
lineages, suggesting that PU.1 has overlapping functions in several
hematopoietic lineages.
Results
Genome-wide occupancy of PU.1 is highly similar in
normal and leukemic erythroid cells
As a first step in identifying the transcriptional network
controlled by PU.1 in immature erythroid cells, we performed
ChIP-Seq in normal proliferating erythroid progenitors derived
from embryonic stem cells (ES-EP) [23] and leukemic erythro-
blasts (MEL cells). We obtained a total of 13,416,531 and
12,710,420 uniquely mapped reads in ES-EP and MEL cells,
respectively. Using two peak calling programs, cisGenome and spp
[24,25], we identified a total of 16,241 peaks of PU.1 occupancy in
ES-EP and 16,599 peaks in MEL cells. We also compared the
number of reads in a given peak in MEL cells and ES-EP and then
assigned a peak as present in both cell types (#5 fold difference in
the number of reads) or enriched in one cell type (.5 fold
difference) (Figure 1A). With this classification scheme, we
identified 16,011 peaks that are shared between the two cell types
and 230 and 588 peaks that are enriched in ES-EP and MEL cells,
respectively (Figure 1B left). Strikingly, more than 95% of the
peaks are shared between the two cell types (Figure 1B left).
Statistical analysis of the data presented in Figure 1A also revealed
a strong similarity between PU.1 binding in the two cell types as
evidenced by a correlation coefficient of 0.800 (p-value
,2.2610
216). This similarity is even visually evident from
examination of the signal tracks of 500 kb windows, such as the
one displayed in Figure 2A. We used qChIP to verify that some of
the rare loci enriched in one cell type are indeed differentially
occupied in the two cell types (Figure S1). Overall, our results
indicate that the binding patterns of PU.1 are highly similar in
normal and leukemic erythroid cells.
Since PU.1 occupies a surprisingly large number (.16,000) of
sites in ES-EP and MEL cells (Figure 1B), it was of interest to
determine whether association of PU.1 with such sites is directed
by a PU.1 consensus binding sequence or whether many of these
sites do not contain such a sequence, which would suggest that
PU.1 occupancy is likely due to protein-protein interactions with
other transcription factors. Analysis of the ChIP-Seq peaks in ES-
EP and MEL cells with the MEME program [26] generated the
position-weighted matrices shown in Figure 2B. The matrices,
which are nearly identical for the two cell types, contain a purine-
rich core sequence, GGAA, corresponding to the previously
described core sequence present in PU.1 binding sites [27,28] and
matching the known binding sequence of the Ets family of
transcription factors [19]. However, our analysis also identified a
bias for an AAAGA sequence upstream of the purine-rich core,
consistent with a recent report [17]. Of note, 13 of 14 positions in
the matrices have a strong bias for purine residues. We found that
74% of peaks shared in ES-EP and MEL cells contain the
consensus motif shown in Figure 2B, indicating that occupancy by
PU.1 at the majority of observed sites is due to direct interaction
between PU.1 and DNA. MEME analysis of the 26% of peaks that
did not contain a PU.1 consensus motif showed enrichment for
highly repetitive sequences that did not match any known
transcription factor binding sites in the TRANSFAC database
(data not shown).
PU.1 binds near transcription start sites and regulates a
large number of genes in immature erythroid cells
To better understand the network of genes that are potentially
regulated by PU.1 in immature erythroid cells, we sought to
associate peaks with genes. We determined that 6,826 of the PU.1
occupied sites shared by ES-EP and MEL cells lie within 2 kb of
the transcription start site (TSS) of known genes (referred to as the
proximal promoter) (Figure 1B right). Moreover, we find that the
greatest concentration of peaks within the proximal promoter is
found at the TSS in both cell types (Figure 2C left). Further
analysis of the genome-wide distribution of peaks showed that
,70% of peaks are found either within a gene structure or in the
flanking 2 kb region, whereas ,30% of peaks are located in
intergenic regions, suggesting the main mechanism of PU.1-
mediated transcriptional regulation is through short-range inter-
actions with the transcriptional machinery (Figure 2C right). This
is in contrast to recent reports on the distribution of PU.1 in other
hematopoietic cell types [17,18,29] and our unpublished data in
macrophages and B-cells (see Discussion). Interestingly, a larger
percentage (,40%) of shared peaks lie within proximal promoters,
whereas a much smaller percentage (,10%) of the peaks enriched
in either ES-EP or MEL cells exhibit this characteristic (Figure
S2A). Moreover, MEME analysis showed that the weighted
matrices of the enriched peaks are slightly different from the
weighted matrices from all peaks (compare Figure 2B and Figure
S2B).
Since PU.1 was found to bind to many genes, it was important
to understand the functional consequences of PU.1 occupancy in
immature erythroid cells. Therefore, we correlated the PU.1
ChIP-Seq data with two types of mRNA profiling in these cells.
First, we compared the transcriptomes of ES-EP and MEL cells.
We found that the mRNA profiles of the two cell types are quite
similar, despite the differences in their phenotypic properties
(Figure S3). Nevertheless, we identified 758 genes that are
occupied by PU.1 near their TSS (PU.1 target genes) and that
are differentially expressed by 2-fold or more between the two cell
types (440 genes upregulated in ES-EP and 318 genes upregulated
in MEL). For these genes, we compared their PU.1 occupancy
(represented as the number of reads in the PU.1 peak(s) near their
TSS) with their relative levels of expression in the two cell types.
Author Summary
Cellular identities are established by master regulatory
transcription factors that promote cell type–specific gene
expression. In some instances such factors also inhibit
differentiation of alternative, closely related lineages. PU.1
is an Ets family transcription factor that is required for
myeloid and B cell development. PU.1 is also expressed in
red blood cell progenitors where it blocks erythroid
terminal differentiation. One mechanism used by PU.1 to
block red blood cell differentiation is by binding to and
inhibiting the erythroid master regulator GATA-1. Here, we
describe another mechanism utilized by PU.1 in erythroid
progenitors. Using chromatin immunoprecipitation and
high-throughput sequencing (ChIP-Seq) combined with
gene expression profiling of erythroid progenitors, we
show that PU.1 controls a large gene network in immature
erythroid cells, including genes in pathways involved in
regulating growth, survival, and differentiation of these
cells. We also find that PU.1 controls many of the same
genes and pathways in other blood cells. The results
indicate that, in addition to activating lineage-specific
genes, master regulatory transcription factors, like PU.1,
also control numerous, widely expressed genes in multiple
cell lineages.
PU.1-Directed Gene Networks in Erythroid Cells
PLoS Genetics | www.plosgenetics.org 2 June 2011 | Volume 7 | Issue 6 | e1001392This analysis showed that genes differentially expressed $2-fold
more in one cell type have higher PU.1 occupancy in that cell type
(Figure 3A). This result suggests that, for genes differentially
expressed between the two cell types, PU.1 occupancy often leads
to upregulation of the gene’s expression in that cell type, and
hence PU.1 is acting on such genes primarily as a transcriptional
Figure 1. Genome-wide binding of PU.1 is very similar in ES-EP and MEL cells. (A) ChIP-Seq peaks were identified as described in Materials
and Methods. A point represents the log2 of the number of sequence reads from ES-EP and MEL cells contained in a peak. Each peak was assigned to
one of two categories based on the ratio of the number of reads in the two cell types. Peaks within a ratio #5 are classified as shared between both
cell types (represented in light blue), whereas peaks with a ratio .5 are enriched in a cell specific manner (represented in red for ES-EP or dark blue
for MEL cells). (B) Venn diagrams illustrate the number of peaks (left) or genes with a peak within 2 kb of TSSs (right) in ES-EP and MEL cells (colors as
A).
doi:10.1371/journal.pgen.1001392.g001
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PLoS Genetics | www.plosgenetics.org 3 June 2011 | Volume 7 | Issue 6 | e1001392Figure 2. Properties of the PU.1 ChIP-Seq peaks in ES-EP and MEL cells. (A) Sample signal tracks of PU.1 ChIP-Seq data from MEL cells and
ES-EP are shown for an ,500 kb region of chromosome 15 in the Integrated Genome Browser (IGB) (Affymetrix), with the y-axis representing the
number of reads. Input DNA controls are also shown for both cell types. (B) Sequence logos for the enriched motifs within PU.1 ChIP-Seq peaks from
MEL (left) and ES-EP (right) cells, derived from MEME motif analysis (see Materials and Methods). (C) The distance between each PU.1 ChIP-Seq peak
and the TSS within 2 kb was computed and the results are binned and plotted for MEL (top left) and ES-EP (bottom left). Peaks were further
annotated by their genomic locations with respect to current gene annotation (right) and classified as proximal promoter (+/22 kb of TSS), 39 end of
gene (+/22 kb of TES), gene body (between +2 kb of TSS and 22 kb of TES), miRNA promoters, or otherwise intergenic regions.
doi:10.1371/journal.pgen.1001392.g002
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PLoS Genetics | www.plosgenetics.org 4 June 2011 | Volume 7 | Issue 6 | e1001392activator. Consistent with this view, we also find in both ES-EP
and MEL cells that the average level of expression of PU.1 target
genes is significantly higher than that of non-PU.1 target genes
(Figure 3B).
To determine how PU.1 affects the expression of its target
genes, we combined the ChIP-Seq data with comparative gene
expression analysis of fetal liver erythroid progenitors from wild-
type E13.5–14.0 embryos and embryos that have a deletion in an
Figure 3. PU.1-dependent gene expression in erythroid cells. (A) PU.1 target genes with a 2-fold expression difference (as measured by
Affymetrix gene array) between MEL and ES-EP cells were identified. The log2 of the number of PU.1 ChIP-Seq reads within peaks of these genes’
promoters are computed and plotted here. Blue circles represent genes for which expression is higher in MEL cells, while red circles represent genes
for which expression is higher in ES-EP. The diameter of each circle is proportional to the degree of difference in gene expression between the two
cell types. (B) The expression levels of genes with and without PU.1 bound at proximal promoters in MEL and ES-EP are shown as boxplots, with the
lower and upper sides of the box representing the lower and upper quartiles, respectively, and the line in the box representing the median
expression value. (C) The log2ratio of the fold change in gene expression from early erythroid progenitors derived from wild-type embryos compared
with PU.1 low embryos for genes bound by PU.1 in MEL (left) or ES-EP (right) are plotted as a function of the number of reads associated with the
peak(s) corresponding to each gene. The positions of the values for Klf1, EpoR, Gfi1b, Myb, Fli1, and Sfpi1 in the plots are labeled.
doi:10.1371/journal.pgen.1001392.g003
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PU.1, resulting in reduced PU.1 expression [30]. mRNA profiling
was performed on very early committed erythroid progenitors
(CD71
med TER119
low) isolated by flow cytometry [31]. The PU.1
mRNA level was found to be reduced by about 70% in the
PU.1 low erythroid progenitors relative to wild-type progenitors
(Figure 3C), similar to reports in other cell types [30,32,33]. The
gene expression analysis revealed that 617 genes are up regulated
and 836 genes are down regulated by PU.1 at least 1.5 fold in
these cells. Of these 1453 genes exhibiting PU.1 dependent
expression in erythroid progenitors, 504 genes (35%) have PU.1
bound within 2 kb of their TSS. Therefore, 7.4% (504/6826) of
PU.1 bound genes are regulated by PU.1. Interestingly, when we
correlated the gene expression changes in erythroid cells to the
level of PU.1 occupancy, we found that genes exhibiting the
strongest PU.1-dependent gene expression changes have a lower
level of PU.1 binding (Figure 3C), a phenomenon that needs to be
further explored. These findings reveal that a large number of
genes are bound and regulated in a PU.1-dependent manner in
erythroid progenitors.
PU.1 regulates genes involved in controlling erythroid
differentiation
Besides PU.1, a number of other factors have been shown to be
involved in regulating erythroid differentiation and erythroid-
specific gene expression. For example, the Ets protein Fli-1 [34,35]
and c-Myb [36,37], like PU.1, inhibit erythroid differentiation,
whereas Gfi-1b [38], the erythropoietin receptor (EpoR) [39], and
the erythroid kruppel-like factor Klf1 [40,41] promote erythroid
differentiation. Comparative gene expression analysis in wild-type
and PU.1 low erythroid progenitors revealed that c-myb and Fli-1
are upregulated by PU.1, whereas Gfi-1b, Klf1, and EpoR are
significantly downregulated (Figure 3C). Furthermore, our ChIP-
Seq data shows PU.1 occupancy either very near to the TSS and/
or within the transcribed region of each of these genes in both
normal ES-EP and MEL cells (Figure 4A and 4B). These data
were confirmed by qChIP in both cell types (Figure 4C and 4D).
Interestingly, we observed very high levels of PU.1 occupancy in
erythroid cells at the Upstream Regulatory Element (URE) lying
,14 kb upstream of the PU.1 (Sfpi1) gene itself (Figure 4AIII and
4C). The URE has been shown to have a strong positive effect on
PU.1 expression in myeloid cells [30,42]. Indeed, deletion of the
URE element resulted in about a 70% reduction of PU.1 in early
fetal liver erythroid progenitors, similar to other cell types,
suggesting PU.1 upregulates its own expression in immature
erythroid cells (Figure 3C, [30,32,33]. The direct positive and
negative effects of PU.1 on expression of the aforementioned genes
fit well with their observed roles in erythroid differentiation,
further strengthening the idea that PU.1 controls the differenti-
ation decision in erythroid cells.
PU.1 regulates several pathways involved in controlling
the growth and survival of immature erythroid cells
To further understand the categories of genes and biological
pathways regulated by PU.1 in erythroid cells, we analyzed the
ChIP-Seq PU.1 targets with Ingenuity Pathway Analysis (IPA)
software. Table S1 shows the ten most significantly over-
represented categories of molecular and cellular functions that
are represented in the PU.1 target genes in both ES-EP and MEL
cells. Interestingly, the two categories at the top are gene
expression and cell cycle. To validate that PU.1 does indeed bind
within the proximal promoter of genes in these two categories, we
carried out qChIP experiments on a total of 32 genes, in both
ES-EP and MEL cells. 84% and 94% of the 32 genes in each cell
type, respectively, were validated for PU.1 occupancy by qChIP
(Figure 4, Figure S1, and Figure S4).
IPA analysis also revealed several important cellular pathways
that are regulated by PU.1 in erythroid cells. For example, 58%
(79/137) of genes involved in the PI3K/Akt signaling pathway are
occupied by PU.1 in ES-EP and MEL cells (Figure 5A). Gene
expression analysis of wild-type and PU.1 low erythroid progenitors
indicates that many genes that stimulate this pathway are positively
regulated by PU.1 (Figure 5A). Another pathway found to be
regulated by PU.1 in erythroid cells is the ERK/MAPK signaling
pathway. 48% (92/192) of the genes in this IPA pathway are
occupied by PU.1 (Figure 5B). As with the PI3K signaling pathway,
gene expression analysis shows that PU.1 upregulates many genes
that stimulate ERK/MAPK signaling (Figure 5B). IPA analysis also
showed that PU.1 regulates the Jak/Stat signaling pathway. 67%
(43/64) of the genes in this pathway are occupied by PU.1, and
many of these genes are upregulated by PU.1 (data not shown). As
discussed below, the PI3K/Akt, ERK/MAPK, and Jak/Stat sig-
naling pathways have all been shown to play important roles in
erythroid cell proliferation, survival and differentiation. Therefore,
these results indicate that PU.1 regulates many genes and pathways
that are crucial for erythroid cell function.
PU.1 levels regulate the number of early erythroid
committed cells in vivo
The foregoing results indicate that PU.1 regulates several
pathways that control the proliferation, survival and differentiation
of erythroid cells. Previous studies reported that ex vivo cultures of
PU.1-depleted fetal liver erythroblasts [10] or preleukemic
erythroblasts [43] exhibit defects in proliferation and increased
cell death. To determine whether PU.1 levels regulate the number
of erythroid progenitors in vivo and the precise stage of its effects,
we analyzed the distribution of five distinct populations of
erythroid cells in fetal livers of mutant PU.1 low embryos and
wild-type littermate embryos [30]. The five populations were
identified by flow cytometry analysis for erythroid-specific
TER119 and the transferrin receptor (CD71), representing
populations of progressively more mature stages of erythroid cells
from the earliest erythroid committed cells (R1 - CD71
med
TER119
low) to late orthochromatophilic erythroblasts and reticulo-
cytes (R5 - CD71
med TER119
high), as described previously [31].
We observed a dose-dependent reduction in the percentage of R1
cells from fetal livers of heterozygous and homozygous mutant
embryos compared to wild-type littermate embryos (Figure 6A).
Whereas, on average 8.6% of the fetal-liver of wild-type embryos
are comprised of R1 cells, this compartment constitutes only 6.1%
(t-test p-value 0.045 compared to wild-type) and 2.7% (t-test p-
value 0.009 compared to wild-type) in heterozygous and
homozygous mutant embryos, respectively. Given that PU.1
promotes several critical pathways involved in promoting survival,
we hypothesized that the reduction of the R1 population may be
due to increased apoptosis of these cells. Indeed, Annexin-V
staining showed that the reduction in R1 cells is due, at least in
part, to increased cell death in this population (Figure 6B). These
results are consistent with a role for PU.1 in promoting widely
utilized pathways for maintaining cell survival in very early
erythroid committed cells in vivo.
PU.1 may cooperate with E2Fs and other transcription
factors in erythroid cells
Lineage determining transcription factors, like PU.1, are
thought to function together with other general and cell type-
PU.1-Directed Gene Networks in Erythroid Cells
PLoS Genetics | www.plosgenetics.org 6 June 2011 | Volume 7 | Issue 6 | e1001392Figure 4. PU.1 regulates genes involved in controlling erythroid differentiation. (A) and (B) Signal tracks of PU.1 ChIP-Seq data from MEL
cells (blue) and ES-EP (red) in the vicinity of the genes depicted schematically (black) using IGB. Myb, Fli1, Gfi1b, and EpoR are transcribed from the
negative strand (right to left), whereas Sfpi1 (PU.1) and Klf1 are expressed in the sense direction (left to right). Input DNA controls are also shown for
both cell types. (C) and (D) qChIP validations of PU.1 occupancy at the regions highlighted in yellow in (A) and (B). qChIP was performed as described
in Materials and Methods with chromatin from MEL cells (left) and ES-EP (right) with primers described in Table S2. A HA antibody was used as an
isotype control. Standard deviations were calculated from triplicate PCR reactions. Similar results were obtained with at least two independent
chromatin preparations.
doi:10.1371/journal.pgen.1001392.g004
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To identify candidate transcription factors that may cooperate
with PU.1 in immature erythroid cells, we scanned the DNA
sequences within the shared PU.1 peaks in ES-EP and MEL cells
for potential transcription factor binding sites using the TRANS-
FAC database (see Materials and Methods). The analysis revealed
Figure 5. PU.1 regulates many genes in the PI3K/Akt and ERK/MAPK signaling pathways. (A) and (B) IPA analysis was performed as
described in Materials and Methods on PU.1 target genes in both ES-EP and MEL cells. The PI3K/Akt and ERK/MAPK signaling pathways were
identified as being significantly over-represented among those genes. The left part of each panel depicts all of the components of the indicated IPA
pathway. Components denoted with a filled yellow circle indicate that the gene for that component is associated with a PU.1 ChIP-Seq peak in both
ES-EP and MEL cells. To the right of each pathway is shown the results of gene expression analysis of the indicated genes in early erythroid
progenitors derived from wild-type embryos relative to PU.1 low embryos.
doi:10.1371/journal.pgen.1001392.g005
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25)
association of PU.1 occupied sites with consensus binding-site
sequences for a number of well-studied and less well-studied
transcription factors (Figure S5A). For example, consistent with a
potential role for PU.1 in cell cycle regulation, consensus binding-
site sequences for E2F factors are found within the PU.1 ChIP-Seq
peaks. Consensus binding site sequences for another factor, ETF,
which has been implicated in control of organ size via effects on
cell proliferation [44], are also enriched within the PU.1 ChIP-Seq
peaks.
To determine if E2F factors are indeed associated with PU.1-
occupied genes in erythroid cells, we performed qChIP studies of
E2F2 and E2F4, two factors that have been reported to be
involved in erythropoiesis [45–48]. One or both factors were
found to bind near the sites occupied by PU.1 in the promoters of
a number of genes in MEL cells (Figure S5B, S5C, and Figure S4).
Occupancy of PU.1 and E2F2 was more prevalent than PU.1 and
E2F4. Interestingly, both E2F2 and E2F4 are present, along with
PU.1, at the PU.1 URE itself, while E2F4 and PU.1 are bound to
the PU.1 promoter region. Although further studies are needed to
understand how E2Fs may cooperate with PU.1 to regulate gene
expression in erythroid and possibly other hematopoietic cells,
these results support the view that lineage-specific transcription
factors work in concert with widely expressed factors.
Figure 6. Reduction in early erythroid progenitors in PU.1 depleted embryos. (A) Fetal livers were isolated from E13.5–14 day old embryos
from WT (URE
+/+), heterozygous (URE
+/2), and homozygous (URE
2/2) animals. Distinct erythroid populations were identified by staining with TER119
and CD71, with representative stainings shown. The percent of R1 cells present from two animals from each genotype was averaged and is displayed
as a bar graph. * t-test,0.05, ** t-test,0.01 compared to URE
+/+. (B) Apoptosis was analyzed by Annexin-V staining of R1 cells. The percentage of
Annexin-V positive cells is shown as an average of two animals from each genotype. *t-test,0.05 compared to URE
+/+.
doi:10.1371/journal.pgen.1001392.g006
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immature erythroid cells and other hematopoietic cells
Since PU.1 is an established transcriptional regulator in myeloid
cells, we sought to determine if genes that we observed to be
regulated by PU.1 in erythroid cells are also regulated by PU.1 in
myeloid cells. We performed qChIP analysis in a myeloid cell line
(32D) at 15 gene targets bound by PU.1 in erythroid cells. We
found PU.1 bound 100% of these genes in myeloid cells
(Figure 7A), consistent with a recent study in which 80% of
PU.1 peaks lying close to TSS were found to overlap in
macrophages and B cells [17]. Since we also observed that PU.1
regulates many genes in the PI3K/Akt and ERK/MAPK
pathways in erythroid cells (Figure 5), we compared our findings
with a published gene expression analysis of PU.1 null cells
undergoing differentiation to macrophages in response to
restoration of PU.1 [49]. We found that, just as we observed in
erythroid cells, many of the genes in these two pathways are
upregulated by PU.1 in macrophages (Figure S6). Additionally, we
also compared all of the genes regulated by PU.1 in early erythroid
committed (R1) cells with the macrophage gene expression data,
as well as with a gene expression analysis of HSC from PU.1
knockdown mice [33]. Of the genes that we found to be occupied
and upregulated by PU.1 at least 1.2-fold in R1 cells, and also
annotated in the two other data sets, 58% (94/162) are also
upregulated in a PU.1 dependent-manner during macrophage
differentiation and 70% (113/162) are similarly regulated in HSC
(Figure 7B left). Similarly, of the genes that we found to be bound
and repressed by PU.1 in erythroid cells and also represented in
the other data sets, 57% (150/265) are also downregulated by
PU.1 in macrophages and 51% (134/265) are repressed in a PU.1-
dependent manner in HSC (Figure 7B right). We conclude that
PU.1 regulates many of the same genes and pathways in immature
erythroid cells, myeloid cells and HSC (see Discussion).
Discussion
The different roles of PU.1 in immature erythroid cells
PU.1 is a master regulatory transcription factor that plays an
essential role in the development of the myeloid and B-cell lineages
[4,5]. However, several lines of evidence suggest that PU.1 also
plays important roles in erythropoiesis (see Introduction and
Figure 6). Some of its effects are likely attributable to its ability to
bind to and repress GATA-1 [3,7,50], but it is also very important
to understand the global gene expression program controlled by
PU.1 in immature erythroid cells. To investigate this program, we
first determined the genome-wide binding patterns of PU.1 in
normal erythroid progenitors and leukemic erythroblasts. We
found that PU.1 occupancy is highly similar in both cell types and
that PU.1 binds in close proximity to a large number of genes
(Figure 1). Unexpectedly, PU.1 appears to occupy more sites
(.16,000) in immature erythroid cells than three essential red
blood cell transcription factors, including GATA-1 (reported to
occupy between 4,000–14,400 sites) [51–54], SCL (,4,500 sites)
[55], and Klf1 (,2,000 sites) [56]. Although some of these
differences may be due to the use of different peak calling methods
or other technical issues such as the use of different antibodies and
different cells, our unpublished results on GATA-1 occupancy
using the same methods and the same cells lead to a similar
conclusion (unpublished data). Interestingly, the genomic distri-
butions of PU.1 in erythroid cells are also dramatically different
from that reported for GATA-1 and Klf1. Whereas we found
,40% of PU.1 bound sites are within 2 kb of TSS (Figure 2), only
,16% of Klf1 bound sites lie within 1 kb of TSS [56], and only
,13% of GATA-1 sites are found within 210 kb of TSS [51],
consistent with our unpublished results indicating that only 9% of
GATA-1 bound sites are within 2 kb of TSS in ES-EP
(unpublished data). These results suggest that PU.1 may act
independently of these factors, at least at a subset of genes in
erythroid progenitors.
Recent work demonstrates that PU.1 directly regulates certain
genes that can themselves affect erythroid differentiation. For
example, we reported that the CDK6 gene is directly upregulated
by PU.1 [11]. Furthermore, we also showed that CDK6, like
PU.1, is rapidly downregulated as erythroid cells enter terminal
differentiation and that constitutive expression of CDK6 blocks
erythroid differentiation [57]. Likewise, Elf-1, another member of
the Ets transcription factor family, was shown to be directly
upregulated by PU.1 and to negatively regulate erythroid
differentiation [22]. Here we report that PU.1 binds in close
proximity to the genes that encode Fli1, c-myb, and PU.1 itself
(Figure 4). We also showed that PU.1 upregulates the expression of
each of these genes (Figure 3C). Like PU.1, Fli1 and c-myb have
been shown to block erythroid differentiation [34,36,37,58–60].
On the other hand, we also found that PU.1 binds in close
proximity to and inhibits expression of genes that promote
erythroid differentiation, such as Gfi-1b, EpoR, and Klf1
(Figure 3C and Figure 4) [38–41]. Thus, our results show that
PU.1 regulates the expression of genes that both inhibit and
promote erythroid differentiation.
However, the results reported here also reveal that PU.1 has a
much broader role in these cells than simply regulating several
factors that control erythroid differentiation. Indeed, the ChIP-Seq
and transcriptome analyses show that PU.1 regulates many genes
involved in several signaling pathways that are critical for
erythropoiesis. These pathways include the PI3K/Akt, ERK/
MAPK, and Jak/Stat pathways (Figure 5 and data not shown), all
of which have been implicated in survival and proliferation of
erythroid progenitors [61–64]. Interestingly, the PI3K/Akt and
Jak/Stat pathways regulate PU.1 levels in erythroid cells [65,66].
Taken together, these findings suggest the existence of a feedback
loop in which PU.1 controls the expression of many genes in these
crucial signaling pathways and these pathways upregulate the
expression of PU.1. Our finding that mice with ,30% of normal
PU.1 levels exhibit a marked reduction in the number of the
earliest committed fetal liver erythroid progenitors (Figure 6) is
consistent with an important role for PU.1 in regulating these
pathways in vivo. Thus, our studies further advance the concept of
master regulatory transcription factors regulating both lineage-
specific genes and more widely expressed genes.
Overlapping functions of PU.1 in several hematopoietic
lineages
Several recent papers reported the genome-wide binding
patterns of PU.1 in macrophages [17,18,20], neutrophilic
precursors [19], B-cells [17], and multipotent progenitors cells
[29]. Interestingly, the genomic distributions of PU.1 in these cells
are quite different from what we observed in erythroid cells. For
example, whereas we found that ,40% of PU.1 occupied sites
map within 2 kb of TSS (the overwhelming majority of these being
bound within 500 bp of TSS) (Figure 2), one study found that only
12% and 18% of PU.1 binding sites in macrophages and B-cells,
respectively, were within 500 bp of TSS [17], and another study in
macrophages found only 20% of such sites to be within 2.5 kb of
TSS [18]. Similarly, only 23% of PU.1 peaks mapped within 1 kb
of TSS in multipotential hematopoietic progenitor cells [29]. It is
likely that part of the reason for these differences is the larger
number of PU.1 occupied sites in the other cell types compared
with erythroid cells. In fact, comparison of ChIP-Seq data for
PU.1-Directed Gene Networks in Erythroid Cells
PLoS Genetics | www.plosgenetics.org 10 June 2011 | Volume 7 | Issue 6 | e1001392Figure 7. PU.1 occupies many of the same gene targets in myeloid and erythroid cells, and PU.1-dependent gene regulation is
similar in HSC, myeloid, and erythroid cells. (A) qChIP was performed for PU.1 as described in Materials and Methods with chromatin from 32D
cells using primers described in Table S2. An HA antibody was used as an isotype control. The same primers were used to show that PU.1 binds close
to these genes in MEL cells and ES-EP (Figure S5). The myogenin gene serves as a negative control. Standard deviations were calculated from
triplicate PCR reactions. Similar results were obtained with at least two independent chromatin preparations. (B) Expression data from PU.1
2/2 cells
stimulated to differentiate into macrophages by the restoration of PU.1 [49] and HSC from PU.1 knockdown mice [33] were used to compare with
PU.1 dependent gene regulation in early erythroid progenitors from PU.1 knockdown mice. Of the PU.1 bound genes in MEL and ES-EP that displayed
a $1.5-fold change in expression, 308 were upregulated and 209 were downregulated. 162 and 265 of these PU.1 dependent genes were annotated
in the other 2 datasets. Venn diagrams display the comparisons between the three datasets of these upregulated genes (left) and downregulated
genes (right).
doi:10.1371/journal.pgen.1001392.g007
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resembles published data, shows that most peaks observed in the
erythroid cells are also present in macrophages and B-cells
(unpublished data). Consistent with this observation, we found that
100% (15/15) of genes occupied by PU.1 in erythroid cells are also
occupied by PU.1 in 32D cells (Figure 7). Furthermore, most of the
genes targeted for regulation by PU.1 in erythroid cells are not
lineage specific; rather they are genes that are widely expressed in
many cell types. This observation begs the question: Does PU.1
control common sets of genes in the several hematopoietic lineages
in which it is expressed? To answer this question, we made several
different types of comparisons of PU.1 gene targets in erythroid
cells, myeloid cells and HSC. For example, we observed that many
PU.1 gene targets in the PI3K/Akt and ERK/MAPK pathways
that we identified in erythroid cells are similarly regulated by PU.1
in macrophages (Figure 5 and Figure S6). We also found that the
majority of genes that are occupied and either positively or
negatively regulated in erythroid cells are similarly regulated in
macrophages and HSC (Figure 7B). Taken together, these
comparative analyses indicate a very significant overlap in PU.1-
dependent gene regulation in erythroid cells and other hemato-
poietic cells.
Much evidence supports the view that PU.1 plays a major role
in establishing cellular identity in B-cells and myeloid cells. Finding
such an extensive overlap among the PU.1 gene targets in several
related but quite distinct hematopoietic cell types raises the
question as to how cellular identity is established by PU.1. We
suggest that the answer lies, at least in part, in the differences in the
levels of PU.1 in different hematopoietic cells. Myeloid cells have
the highest level of PU.1, B-cells have an intermediate level [67],
and immature erythroid cells have a much lower level [68,69].
Overexpression of PU.1 in B-cells reprograms the cells to ma-
crophages [70], similar to what has been reported in MEL cells
[71,72]. These observations, taken together with our finding that
many widely expressed genes are occupied and similarly regulated
by PU.1 in immature erythroid cells, myeloid cells and HSC
(Figure 7 and Figure S6), suggest that PU.1 has both shared and
lineage-specific functions in these lineages, depending on the
level of the factor in each lineage. We suggest that even at low
concentrations, PU.1 can promote ubiquitous cellular functions
such as proliferation and survival. Indeed, PU.1 has been reported
to promote proliferation of both erythroid progenitors [10,43] and
bone marrow derived macrophages [73]. However, higher con-
centrations of PU.1 are required to promote its lineage-specific
functions [67,70–72]. It will be interesting to determine whether
this principle of overlapping gene networks regulated by a
transcription factor in several related lineages, proposed here for
PU.1, is applicable to master transcriptional regulators in other
developmental systems.
Materials and Methods
Cell culture
MEL cells (clone DS19) stably expressing a GATA-1-estrogen
receptor ligand-binding domain (ER) fusion protein (GATA-1/
ER) was described previously [74]. ES-EP cells were cultured as
previously described [23]. Further details can be found in Text S1.
qChIP and ChIP-Seq
qChIP was performed as previously described [11]. ChIP for
ChIP-Seq analysis was performed similarly but using 5610
7 cells
and 60 mg of anti-PU.1 antiserum. A list of antibodies used in this
study, along with further information on processing of ChIP-Seq
samples can be found in Text S1. A summary of PU.1 ChIP-Seq
data can be found in Dataset S1.
ChIP-Seq data analysis
Uniquely mapped reads from ChIP-Seq data were mapped to
the mouse genome (mm9). Details on peak calling and subsequent
statistical analysis can be found in Text S1. ChIP-Seq data is
deposited on GEO database under the accession number
GSE21953.
Gene expression data analysis
Total RNA was isolated from duplicate cultures of proliferating
ES-EP and MEL cells or R1 cells sorted from two wild-type and
URE
2/2 animals using the RNeasy Kit (Qiagen) following the
manufacturer’s instructions. Total RNA was further processed by
the AECOM microarray facility using the standard Affymetrix
pipeline and hybridized to GeneChip Mouse Gene 1.0 ST
(Affymetrix). This expression data can be accessed from the GEO
database under the accession number GSE21953. Subsequent
statistical analysis is described in Text S1.
Motif enrichment analysis
For each PU.1 peak, we extracted a 500-bp sequence around
the peak center (i.e., +/2250 bp) and used it for searching de novo
motifs with the MEME software [26] and also known motifs in the
TRANSFAC software suit (release 11) [75]. For motif analysis
with TRANSFAC, we utilized the program MATCH in the
TRANSFAC software package and applied the default parameters
for minimizing the false positive rate (i.e., minFP option). As our
background control, we ran MATCH against a randomly chosen
set of 10,000 sequences (500-bp each). The enrichment of a known
motif in PU.1 peaks was then calculated as the ratio of the motif
occurrence frequency in PU.1 peaks and its corresponding
frequency in background sequences. P-value was derived with a
binomial test of the difference in motif frequency.
Supporting Information
Dataset S1 PU.1 ChIP-Seq Summary. Summary of PU.1 ChIP-
Seq data. File includes all peaks identified in ES-EP and MEL
cells. Peaks that are within 2 kb of TSS are assigned with a RefSeq
gene.
Found at: doi:10.1371/journal.pgen.1001392.s001 (2.05 MB
XLS)
Figure S1 Comparisons of ChIP-Seq and qChIP data for loci
differentially occupied by PU.1 in MEL cells and ES-EP. (A)
Comparisons for loci exhibiting enriched occupancy of PU.1 in
MEL cells. Panels 1–3 display signal tracks corresponding to 1) a
gene-poor region on chromosome 15, 2) the region near the Mxi1
gene, 3) the region near the Dnmt3a gene. Panel 4 shows qChIP
analyses near the peaks denoted with arrows in panels 1–3. A HA
antibody was used as an isotype control. Sequences of qChIP
primers are shown in Table S2. Standard deviations represent the
errors from triplicate PCR reactions. Similar results were obtained
with at least 2 independent chromatin preps. (B) As in (A) for loci
exhibiting enriched occupancy of PU.1 in ES-EP. Panels 1–3
display signal tracks corresponding to 1) a gene-poor region on
chromosome 8, 2) the region near the Mta3 gene, 3) the region
near the Gpr149 gene.
Found at: doi:10.1371/journal.pgen.1001392.s002 (0.41 MB PDF)
Figure S2 Properties of PU.1 ChIP-Seq peaks enriched in MEL
cells or ES-EP. (A) The percentage of PU.1 ChIP-Seq peaks lying
within the indicated distance from the closest TSS was calculated
PU.1-Directed Gene Networks in Erythroid Cells
PLoS Genetics | www.plosgenetics.org 12 June 2011 | Volume 7 | Issue 6 | e1001392separately for peaks shared by the two cell types (Overlap) or
enriched in either MEL cells or ES-EP, as described in Materials
and Methods. (B) The derived position-weighted matrices from
MEME analyses of PU.1 ChIP-Seq peaks enriched in MEL cells
(top) and ES-EP (bottom) are shown. The thymidine [T] and
adenosine [A] residues that differ relative to matrices derived from
MEME analyses of all PU.1 ChIP-Seq peaks in each cell type
(Figure 2B) are highlighted.
Found at: doi:10.1371/journal.pgen.1001392.s003 (0.27 MB PDF)
Figure S3 High correlation of gene expression in MEL cells and
ES-EP. Gene expression levels were obtained separately for MEL
cells and ES-EP with the Affymetrix microarray platform. After
data processing and normalization, the relative expression of genes
in the two samples are shown here as a scatter plot with larger
units representing higher expression. The Pearson’s correlation
coefficient and its statistical significance are shown at the top of the
figure.
Found at: doi:10.1371/journal.pgen.1001392.s004 (0.77 MB PDF)
Figure S4 qChIP validation of PU.1 occupancy near genes
involved in gene regulation and cell cycle regulation. (A) and (B)
qChIP was performed as described in Materials and Methods with
chromatin from MEL cells (top) and ES-EP (bottom) with primers
described in Table S2. The genes analyzed represent examples of
genes from the IPA gene expression (A) and cell cycle (B)
categories that have PU.1 ChIP-Seq peaks within +/22k bo f
their TSS. Myogenin and b-HS2 serve as negative and positive
controls, respectively. A HA antibody was used as an isotype
control. Standard deviations were calculated from triplicate PCR
reactions. Similar results were obtained with at least two inde-
pendent chromatin preparations.
Found at: doi:10.1371/journal.pgen.1001392.s005 (0.16 MB PDF)
Figure S5 E2F factors occupy PU.1 target genes in MEL cells.
(A) DNA sequences from PU.1 ChIP-Seq peaks within the
proximal promoter in both ES-EP and MEL cells were analyzed
using the TRANSFAC database as described in Materials and
Methods. The names of the ten most significant observed
transcription factor motifs (p-value,10
25) that were found in at
least 10% of peaks and $2 fold enriched over the expected
frequency are shown. The ratio between observed frequency and
expected frequency is represented by a log2ratio. (B) and (C)
qChIP analysis of E2F2 (B) and E2F4 (C) occupancy was
performed as described in Materials and Methods at the indicated
PU.1 target genes in MEL cells. A HA antibody was used as
an isotype control. Standard deviations were calculated from
triplicate PCR reactions. Similar results were obtained with at least
two independent chromatin preparations. The myogenin locus
serves as a negative control.
Found at: doi:10.1371/journal.pgen.1001392.s006 (0.16 MB PDF)
Figure S6 PU.1 promotes PI3K/Akt and ERK/MAPK signal-
ing in macrophages. A previously published [49] gene expression
analysis of PU.1
2/2 cells induced to differentiate into macro-
phages was used to generate heatmaps depicting the response of
the indicated genes in the PI3K/Akt and ERK/MAPK signaling
pathways to the activation of PU.1. The genes shown in this
analysis are the same as the genes found to be regulated by PU.1 in
MEL cells (Figure 5).
Found at: doi:10.1371/journal.pgen.1001392.s007 (0.11 MB PDF)
Table S1 Results of Ingenuity Pathway Analysis of PU.1 Target
Genes. Ingenuity Pathway Analysis was performed on genes with
one or more PU.1 ChIP-Seq peaks within 2 kb of TSS in both
MEL and ES-EP. The ten most significant molecular and cellular
functions identified are listed in descending order of significance.
The number of genes associated with a given function and bound
by PU.1 is shown. p-values have been corrected for multiple
testing using the Holm-Bonferroni method.
Found at: doi:10.1371/journal.pgen.1001392.s008 (0.01 MB
DOCX)
Table S2 Primers used in this study.
Found at: doi:10.1371/journal.pgen.1001392.s009 (0.02 MB
DOCX)
Text S1 Supplemental Materials and Methods.
Found at: doi:10.1371/journal.pgen.1001392.s010 (0.06 MB
DOC)
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